rTMS Treatment in Vascular Parkinsonism

Launched by INJE UNIVERSITY · Oct 22, 2018

Keywords

ClinConnect Summary

This clinical trial is investigating a treatment called repetitive transcranial magnetic stimulation, or rTMS, for people with vascular parkinsonism (VP). VP is a type of movement disorder caused by problems with blood flow to the brain, leading to symptoms like difficulty walking, balance issues, and a greater chance of falling. The goal of this study is to see if rTMS can help improve these symptoms and make daily life easier for those affected by VP.

To be part of this trial, participants must be at least 18 years old and diagnosed with vascular parkinsonism. However, individuals who are pregnant or have certain medical conditions, like seizure disorders or implanted devices in their bodies, will not be eligible. The trial is not yet recruiting participants, but when it begins, those who join can expect to receive rTMS treatment in a safe, non-invasive way. This study aims to find new options for managing the challenges of vascular parkinsonism, which can be very frustrating for patients and their families.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Vascular parkinsonism
• • age 18 and older
• Exclusion Criteria:
• • pregnant or any, other medical, surgical, neurological or psychiatric conditions
• • other restrictions which prevent you from undergoing TMS recording, such as; surgically or traumatically implanted foreign bodies such as a pacemaker, an implanted medication pump, a metal plate in the skull, or metal inside the skull or eyes (other than dental appliances or fillings), and/ or heart/cardiac lines
• • any past or current history of seizure disorder or epilepsy
• • unable to give informed consent